Biotech takeover target Abivax sinks over 30% as cancer cases cloud trial data for bowel disease drug
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC